Back to Clinical Trials

Brief Title: Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) That is Either Persistent or Recurrent Following BCG Induction or That is Naïve to BCG Treatment (KEYNOTE-676)

INTRODUCTION

  • Org Study ID: 3475-676
  • Secondary ID: MK-3475-676, 2018-001967-22, 194713
  • NTC ID: NCT03711032
  • Sponsor: Merck Sharp & Dohme Corp.
Merck Oncology Clinical Trials Information

BRIEF SUMMARY

This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with BCG, compared to BCG monotherapy, in participants with HR NMIBC that is either persistent or recurrent following adequate BCG induction (Cohort A), or that is naïve to BCG treatment (Cohort B). The primary hypothesis for Cohort A is that the combination of pembrolizumab plus BCG has a superior complete response rate (CRR) as assessed by central pathology review compared to BCG in participants with carcinoma in situ (CIS). The primary hypothesis for Cohort B is that the combination of pembrolizumab plus BCG (either reduced maintenance or full maintenance) has a superior Event Free Survival (EFS) compared to BCG.

  • Overall Status
    Recruiting
  • Start Date
    December 24, 2018
  • Phase
    Phase 3
  • Study Type
    Interventional

PRIMARY OUTCOMES

Primary Outcome 1 - Measure: Complete Response Rate (CRR) by Blinded Independent Central Review (BICR) (Cohort A)

Primary Outcome 1 - Timeframe: Up to ~3.5 years

Primary Outcome 2 - Measure: Event-Free Survival (EFS) (Cohort B)

Primary Outcome 2 - Timeframe: Up to ~5 years

CONDITION

  • High-risk Non-muscle Invasive Bladder Cancer

ELIGIBILITY

Inclusion Criteria:
Has histologically-confirmed diagnosis of non-muscle invasive (T1, high grade Ta and/or CIS) UC of the bladder

- Has undergone cystoscopy/ transurethral resection of bladder tumor (TURBT) to remove all resectable disease

- Has provided tissue for biomarker analysis

- Has Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2

- Has adequate organ function

- During the treatment period and for ≥7 days after the last dose of BCG, male participants are EITHER abstinent from heterosexual intercourse as their preferred and usual lifestyle and agree to remain abstinent, OR, must agree to use contraception unless confirmed to be azoospermic

- Female participants who are not pregnant, not breastfeeding, and either not a woman of child bearing potential (WOCBP); or are a WOCBP who agrees to use a contraception method that is highly effective or remains abstinent from heterosexual intercourse during the treatment period and for ≥7 days after the last dose of BCG or 120 days after the last dose of pembrolizumab, whichever comes last
BCG Post-induction Cohort (Cohort A) Only
Has been treated with one adequate course of BCG induction therapy for the treatment of HR NMIBC

- Following adequate BCG induction therapy, must have persistent or recurrent HR NMIBC
Exclusion Criteria:
Has a history of or concurrent locally advanced (i.e., T2, T3, T4) or metastatic UC

- Has concurrent extra-vesical (ie, urethra, ureter, renal pelvis) non-muscle invasive urothelial carcinoma or invasive prostatic UC

- Has received prior therapy with anti-PD-1, anti-PD-L1, or anti-PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor

- Has received prior systemic anti-cancer therapy including investigational agents within 4 weeks of start of study treatment

- Is currently participating in or has participated in a study of an investigational agent or has used an investigational device within 4 weeks of start of study treatment

- Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy or any other form of immunosuppressive therapy within 7 days of start of study treatment

- Has a known additional malignancy that is progressing or requires active treatment within the past 3 years

- Has an active autoimmune disease that has required systemic treatment in past 2 years

- Has a history of (non-infectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease

- Has one or more of the following contraindications to BCG: prior BCG sepsis or systemic infection, total bladder incontinence, or an adverse experience to a previous BCG instillation that resulted in treatment discontinuation and precludes retreating with BCG

- Has an active infection requiring systemic therapy

- Has a known history of human immunodeficiency virus (HIV) infection

- Has a known history of Hepatitis B or known active Hepatitis C virus infection

- Has current active tuberculosis

- Has had an allogenic-tissue/solid organ transplant

- Has any contraindication(s) to IV contrast or is otherwise unable to have computed tomography urothelial (CTU) imaging with IV contrast performed
BCG Post-induction Cohort (Cohort A) Only - Has persistent T1 disease following an induction course of BCG
BCG Naïve Cohort (Cohort B) Only
- Has received any prior treatment with BCG for their NMIBC within the past 2 years prior to study entry

Gender: All

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

OFFICIAL INFORMATION

Name: Medical Director

Role: Study Director

Affiliation: Merck Sharp & Dohme Corp.

Overall Contact

Name: Medical Director

Phone: 1-888-577-8839

Email: Trialsites@merck.com

LOCATION

Facility Status Contact
Facility: Mayo Clinic ( Site 1094)
Phoenix, Arizona 85054
United States
Status: Recruiting Contact: Contact
Study Coordinator
520-784-7000
Facility: Arizona Institute of Urology (AIU) - Northwest ( Site 1096)
Tucson, Arizona 85704
United States
Status: Recruiting Contact: Contact
Study Coordinator
310-794-3421
Facility: UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro
Los Angeles, California 90095
United States
Status: Recruiting Contact: Contact
Study Coordinator
714-456-8148
Facility: University of California Irvine Medical Center ( Site 1061)
Orange, California 92868
United States
Status: Recruiting Contact: Contact
Study Coordinator
310-602-5005
Facility: Skyline Urology ( Site 1065)
Torrance, California 90505
United States
Status: Recruiting Contact: Contact
Study Coordinator
303-996-9649
Facility: Colorado Clinical Research ( Site 1100)
Lakewood, Colorado 80228
United States
Status: Recruiting Contact: Contact
Study Coordinator
305-243-2177
Facility: Sylvester Comprehensive Cancer Center ( Site 1056)
Miami, Florida 33136
United States
Status: Recruiting Contact: Contact
Study Coordinator
404-778-4823
Facility: Emory School of Medicine ( Site 1076)
Atlanta, Georgia 30322
United States
Status: Recruiting Contact: Contact
Study Coordinator
316-636-6141
Facility: Advanced Urology ( Site 1092)
Roswell, Georgia 30076
United States
Status: Recruiting Contact: Contact
Study Coordinator
313-916-8862
Facility: Wichita Urology Group ( Site 1086)
Wichita, Kansas 67226
United States
Status: Recruiting Contact: Contact
Study Coordinator
248-786-0467
Facility: Henry Ford Health System ( Site 1062)
Detroit, Michigan 48202
United States
Status: Recruiting Contact: Contact
Study Coordinator
973-971-5373
Facility: Michigan Institute of Urology ( Site 1077)
Troy, Michigan 48084
United States
Status: Recruiting Contact: Contact
Study Coordinator
732-235-6048
Facility: Morristown Medical Center ( Site 1090)
Morristown, New Jersey 07960
United States
Status: Recruiting Contact: Contact
Study Coordinator
646-501-8206
Facility: Rutgers Cancer Institute of New Jersey ( Site 1059)
New Brunswick, New Jersey 08901
United States
Status: Recruiting Contact: Contact
Study Coordinator
31547841857794
Facility: Northwell Health- Monter Cancer Center ( Site 1080)
Lake Success, New York 11042
United States
Status: Recruiting Contact: Contact
Study Coordinator
614-366-7421
Facility: Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 1074)
New York, New York 10016
United States
Status: Recruiting Contact: Contact
Study Coordinator
971-262-9600
Facility: Associated Medical Professionals of NY ( Site 1078)
Syracuse, New York 13210
United States
Status: Recruiting Contact: Contact
Study Coordinator
610-667-0458
Facility: Tri-State Urologic Services PSC, Inc. ( Site 1091)
Cincinnati, Ohio 45212
United States
Status: Recruiting Contact: Contact
Study Coordinator
717-431-2285
Facility: Ohio State University Arthur G James Cancer Hospital & Richard J Solove Research Institute ( Site 10
Columbus, Ohio 43210
United States
Status: Recruiting Contact: Contact
Study Coordinator
8434491010257
Facility: OHSU Knight Cancer Institute ( Site 1075)
Portland, Oregon 97210
United States
Status: Recruiting Contact: Contact
Study Coordinator
615-250-9268
Facility: MidLantic Urology ( Site 1071)
Bala-Cynwyd, Pennsylvania 19004
United States
Status: Recruiting Contact: Contact
Study Coordinator
214-580-1485
Facility: Lancaster Urology ( Site 1079)
Lancaster, Pennsylvania 17604
United States
Status: Recruiting Contact: Contact
Study Coordinator
214-645-8787
Facility: University of Pennsylvania ( Site 1088)
Philadelphia, Pennsylvania 19104
United States
Status: Recruiting Contact: Contact
Study Coordinator
802-656-9926
Facility: Carolina Urologic Research Center ( Site 1085)
Myrtle Beach, South Carolina 29572
United States
Status: Recruiting Contact: Contact
Study Coordinator
757-452-3463
Facility: Urology Associates [Nashville, TN] ( Site 1072)
Nashville, Tennessee 37209
United States
Status: Recruiting Contact: Contact
Study Coordinator
+4373276777727
Facility: Urology Clinics of North Texas, PLLC ( Site 1064)
Dallas, Texas 75231
United States
Status: Recruiting Contact: Contact
Study Coordinator
+435050424811
Facility: University Of Texas Southwestern Medical Center ( Site 1053)
Dallas, Texas 75390
United States
Status: Recruiting Contact: Contact
Study Coordinator
+4367761942300
Facility: University of Vermont Medical Center ( Site 1057)
Burlington, Vermont 05401
United States
Status: Recruiting Contact: Contact
Study Coordinator
+3281423858
Facility: Urology of Virginia ( Site 1070)
Virginia Beach, Virginia 23462
United States
Status: Recruiting Contact: Contact
Study Coordinator
+3253724378
Facility: Ordensklinikum Linz GmbH Elisabethinen ( Site 0052)
Linz, Oberosterreich 4020
Austria
Status: Recruiting Contact: Contact
Study Coordinator
6048515667
Facility: Univ. Klinik f. Urologie Innsbruck ( Site 0051)
Innsbruck, Tirol 6020
Austria
Status: Recruiting Contact: Contact
Study Coordinator
2505929988
Facility: Medical University Vienna ( Site 0054)
Vienna, Wien 1090
Austria
Status: Recruiting Contact: Contact
Study Coordinator
5068574780
Facility: Universitaetsklinik Salzburg ( Site 0053)
Salzburg, Antwerpen 5020
Austria
Status: Recruiting Contact: Contact
Study Coordinator
4169462246
Facility: UZA University Hospital Antwerp ( Site 0105)
Edegem, Namur 2650
Belgium
Status: Recruiting Contact: Contact
Study Coordinator
4185411000
Facility: CHU UCL Namur Site de Godinne ( Site 0103)
Yvoir, Oost-Vlaanderen 5530
Belgium
Status: Recruiting Contact: Contact
Study Coordinator
5142523400x5766
Facility: O.L.V. Ziekenhuis Aalst ( Site 0106)
Aalst, Oost-Vlaanderen 9300
Belgium
Status: Recruiting Contact: Contact
Study Coordinator
8193461110x12827
Facility: AZ Maria Middelares Gent ( Site 0102)
Gent, Oost-Vlaanderen 9000
Belgium
Status: Recruiting Contact: Contact
Study Coordinator
418525444420414
Facility: UZ Gent ( Site 0101)
Gent, British Columbia 9000
Belgium
Status: Recruiting Contact: Contact
Study Coordinator
+50683384787
Facility: Exdeo Clinical Research Inc. ( Site 0165)
Abbotsford, British Columbia V2T 1X8
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+358331164621
Facility: Silverado Resarch Inc. ( Site 0155)
Victoria, New Brunswick V8T 2C1
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+33146251961
Facility: Horizon Health Network ( Site 0160)
Moncton, Ontario E1C 6Z8
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+498941402522
Facility: Princess Margaret Cancer Centre ( Site 0153)
Toronto, Quebec M5G 2M9
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+49963033302
Facility: CIUSSS du Saguenay-Lac-St-Jean ( Site 0164)
Chicoutimi, Quebec G7H 5H6
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+4993120132037
Facility: CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0157)
Montreal, Quebec H1T 2M4
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+496512082680
Facility: CHUS - Hopital Fleurimont ( Site 0152)
Sherbrooke, Pirkanmaa J1H 5N4
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+49-3641-9-329901
Facility: CHU de Quebec - Hotel-Dieu de Quebec ( Site 0151)
Quebec, Loire-Atlantique G1R 2J6
Canada
Status: Recruiting Contact: Contact
Study Coordinator
+302610999791
Facility: Policlinico San Bosco ( Site 0600)
San Jose, Bayern 10103
Costa Rica
Status: Recruiting Contact: Contact
Study Coordinator
+302413502811
Facility: Tampere University Hospital [Tampere Finland] ( Site 0201)
Tampere, Bayern 33520
Finland
Status: Recruiting Contact: Contact
Study Coordinator
+302310898721
Facility: Hôpital Foch-Urology department ( Site 1351)
Suresnes, Bayern 92151
France
Status: Recruiting Contact: Contact
Study Coordinator
+50240492110
Facility: Klinikum Rechts der Isar. Technischen Universitaet Muenchen ( Site 0266)
Munich, Rheinland-Pfalz 81675
Germany
Status: Recruiting Contact: Contact
Study Coordinator
3672507323
Facility: Klinikum Weiden ( Site 0259)
Weiden In Der Oberpfalz, Thuringen 92637
Germany
Status: Recruiting Contact: Contact
Study Coordinator
+36709411312
Facility: Universitaetsklinikum Wuerzburg ( Site 0265)
Wuerzburg, Achaia 97080
Germany
Status: Recruiting Contact: Contact
Study Coordinator
+39022643789
Facility: Krankenhaus der Barmherzigen Brüder Trier-Abteilung für Urologie und Kinderurologie ( Site 0262)
Trier, Thessalia 54292
Germany
Status: Recruiting Contact: Contact
Study Coordinator
+390223902402
Facility: Universitaetsklinikum Jena ( Site 0252)
Jena, Baranya 07747
Germany
Status: Recruiting Contact: Contact
Study Coordinator
+390557949920
Facility: General University Hospital of Patras ( Site 0302)
Patra, Csongrad 265 04
Greece
Status: Recruiting Contact: Contact
Study Coordinator
+393477835206
Facility: University Hospital of Larissa ( Site 0301)
Larissa, Lombardia 411 10
Greece
Status: Recruiting Contact: Contact
Study Coordinator
+390805555355
Facility: Antikarkiniko Nosokomeio Thessalonikis THEAGENIO ( Site 0303)
Thessaloniki, Lombardia 54 639
Greece
Status: Recruiting Contact: Contact
Study Coordinator
+390871357783
Facility: Grupo Medico Angeles-Grupo Medico Angeles ( Site 1453)
Guatemala, Toscana 01015
Guatemala
Status: Recruiting Contact: Contact
Study Coordinator
+39091479432
Facility: Pécsi Tudományegyetem Klinikai Központ-Urológiai Klinika ( Site 1304)
Pécs, Trentino-Sudtirol 7621
Hungary
Status: Recruiting Contact: Contact
Study Coordinator
+390630154953
Facility: Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Urológiai Klinika ( Site 1303)
Szeged, Aomori 6725
Hungary
Status: Recruiting Contact: Contact
Study Coordinator
+390458123876
Facility: Ospedale San Raffaele ( Site 0362)
Milano, Ehime 20132
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81172335111
Facility: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0353)
Milan, Ibaraki 20133
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81899645111
Facility: Azienda Ospedaliero Universitaria Careggi ( Site 0360)
Firenze, Kanagawa 50134
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81298533900
Facility: Osp Generale Reg di Bolzano ( Site 0355)
Bolzano, Kanagawa 39100
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81427788111
Facility: Istituto Tumori Giovanni Paolo II ( Site 0357)
Bari, Nara 70124
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81468222710
Facility: Ospedale Clinicizzato Santissima Annunziata ( Site 0361)
Chieti, Seoul 66100
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81744223051
Facility: Ospedale Buccheri La Ferla Fatebenefratelli ( Site 0352)
Palermo, Zuid-Holland 90123
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81922913434
Facility: Policlinico Universitario A. Gemelli ( Site 0358)
Roma, Akershus 00168
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81669451181
Facility: A.O.U. di Verona - Ospedale Civile Maggiore Borgo Trento ( Site 0356)
Verona, Rogaland 37126
Italy
Status: Recruiting Contact: Contact
Study Coordinator
+81666452121
Facility: Hirosaki University Hospital ( Site 0407)
Hirosaki, Lima 036-8563
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+81338136111
Facility: Ehime University Hospital ( Site 0414)
Toon, Dolnoslaskie 791-0295
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+81333531211
Facility: University of Tsukuba Hospital ( Site 0412)
Tsukuba, Kujawsko-pomorskie 305-8576
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+82230103980
Facility: Kitasato University Hospital ( Site 0403)
Sagamihara, Malopolskie 252-0375
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+821099288097
Facility: Yokosuka Kyosai Hospital ( Site 0406)
Yokosuka, Mazowieckie 238-8558
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+82220720361
Facility: Nara Medical University Hospital ( Site 0411)
Kashihara, Mazowieckie 634-8522
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+60379492120
Facility: Chiba Cancer Center ( Site 0401)
Chiba, Pomorskie 260-8717
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+31433876543
Facility: Harasanshin Hospital ( Site 0410)
Fukuoka, Pomorskie 812-0033
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+31107040704
Facility: Osaka International Cancer Institute ( Site 0413)
Osaka, Slaskie 541-8567
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+4767960000
Facility: Osaka City University Hospital ( Site 0404)
Osaka, Wielkopolskie 545-8586
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+4751518000
Facility: Medical Hospital, Tokyo Medical And Dental University ( Site 0409)
Tokyo, Madrid, Comunidad De 113-8519
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+5113230402
Facility: Keio University Hospital ( Site 0405)
Tokyo, Navarra 160-8582
Japan
Status: Recruiting Contact: Contact
Study Coordinator
+51997468543
Facility: Asan Medical Center ( Site 0804)
Songpagu, Basel-Stadt 05505
Korea, Republic of
Status: Recruiting Contact: Contact
Study Coordinator
+51992756559
Facility: Korea University Anam Hospital ( Site 0801)
Seoul, Highland 02841
Korea, Republic of
Status: Recruiting Contact: Contact
Study Coordinator
+48601143281
Facility: Seoul National University Hospital ( Site 0802)
Seoul, London, City Of 03080
Korea, Republic of
Status: Recruiting Contact: Contact
Study Coordinator
+48563004380
Facility: University Malaya Medical Centre ( Site 1180)
Kuala Lumpur, 59100
Malaysia
Status: Recruiting Contact: Contact
Study Coordinator
+48691666578
Facility: Maastricht University Medical Centre ( Site 0453)
Maastricht, 6202AZ
Netherlands
Status: Recruiting Contact: Contact
Study Coordinator
+48607460282
Facility: Erasmus MC ( Site 0451)
Rotterdam, 3015 GD
Netherlands
Status: Recruiting Contact: Contact
Study Coordinator
+48598460340
Facility: Akershus University Hospital ( Site 0553)
Lorenskog, 1478
Norway
Status: Recruiting Contact: Contact
Study Coordinator
+48616632513
Facility: Stavanger universitetssykehus ( Site 0555)
Stavanger, 4011
Norway
Status: Recruiting Contact: Contact
Study Coordinator
+351253027249
Facility: Hospital Nacional Guillermo Almenara Irigoyen ( Site 0601)
La Victoria, 15033
Peru
Status: Recruiting Contact: Contact
Study Coordinator
+351239400200
Facility: Hospital Militar Central [Lima, Peru] ( Site 0604)
Lima, 15076
Peru
Status: Recruiting Contact: Contact
Study Coordinator
+351217805056
Facility: Oncosalud ( Site 0603)
Lima, Li 41
Peru
Status: Recruiting Contact: Contact
Study Coordinator
+351217229892
Facility: Uniwesytecki Szpital Kliniczny we Wroclawiu ( Site 0669)
Wroclaw, 50-556
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+351225084000
Facility: Nasz Lekarz Przychodnie Medyczne ( Site 0679)
Torun, 87-100
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+34914521987
Facility: Urologica Praktyka Lekarska Adam Marcheluk ( Site 0654)
Siedlce, 08-110
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+34982296459
Facility: Luxmed Onkologia sp. z o. o. ( Site 0653)
Warszawa, 01-748
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+34914269070
Facility: Szpital Specjalistyczny w Koscierzynie Sp. z o.o. ( Site 0671)
Koscierzyna, 83-400
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+34917878600
Facility: Wojewodzki Szpital Specjalistyczny im. Janusza Korczaka w Slupsku ( Site 0655)
Slupsk, 76-200
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+34913368263
Facility: Clinical Research Center Sp. z o.o. ( Site 0674)
Poznan, 60-848
Poland
Status: Recruiting Contact: Contact
Study Coordinator
+34961244188
Facility: 2CA Braga. Centro Clinico Academico ( Site 0705)
Braga, 4710-243
Portugal
Status: Recruiting Contact: Contact
Study Coordinator
+41615565477
Facility: Inst. Portugues de Oncologia de Coimbra Francisco Gentil EPE ( Site 0704)
Coimbra, 3000-075
Portugal
Status: Recruiting Contact: Contact
Study Coordinator
+41223727876
Facility: CHLN Hospital Santa Maria ( Site 0702)
Lisboa, 1649-035
Portugal
Status: Recruiting Contact: Contact
Study Coordinator
+41442555440
Facility: Inst. Portugues de Oncologia de Lisboa Francisco Gentil EPE ( Site 0708)
Lisboa, 4200-072
Portugal
Status: Recruiting Contact: Contact
Study Coordinator
+905323430723
Facility: Inst. Portugues de Oncologia de Porto Francisco Gentil EPE ( Site 0701)
Porto, 28223
Portugal
Status: Recruiting Contact: Contact
Study Coordinator
+905055250505
Facility: Hospital Universitario Quiron Madrid ( Site 0862)
Pozuelo de Alarcon, 31008
Spain
Status: Recruiting Contact: Contact
Study Coordinator
+905322679838
Facility: Fundacio Puigvert ( Site 0864)
Barcelona, 27003
Spain
Status: Recruiting Contact: Contact
Study Coordinator
+442078828505
Facility: Hospital Universitario Lucus Augusti ( Site 0852)
Lugo, 28009
Spain
Status: Recruiting Contact: Contact
Study Coordinator
+442087253362
Facility: Hospital Universitario Gregorio Maranon ( Site 0854)
Madrid, 28027
Spain
Status: Recruiting Contact: N/A
Facility: MD Anderson Cancer Center Madrid ( Site 0859)
Madrid, 28034
Spain
Status: Recruiting Contact: N/A
Facility: Hospital Universitario Ramon y Cajal ( Site 0857)
Madrid, 28046
Spain
Status: Recruiting Contact: N/A
Facility: Hospital Universitario La Paz ( Site 0866)
Madrid, 46026
Spain
Status: Recruiting Contact: N/A
Facility: Hospital La Fe de Valencia ( Site 0855)
Valencia, 4031
Spain
Status: Recruiting Contact: N/A
Facility: Universitaetsspital Basel ( Site 1201)
Basel, 1205
Switzerland
Status: Recruiting Contact: N/A
Facility: Hopitaux Universitaires de Geneve HUG ( Site 1204)
Geneve, 8091
Switzerland
Status: Recruiting Contact: N/A
Facility: Universitaetsspital Zurich ( Site 1203)
Zurich, 26480
Switzerland
Status: Recruiting Contact: N/A
Facility: Eskisehir Osmangazi Universitesi Hastanesi ( Site 0953)
Eskisehir, 34722
Turkey
Status: Recruiting Contact: N/A
Facility: TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 0963)
Istanbul, 35340
Turkey
Status: Recruiting Contact: N/A
Facility: Dokuz Eylul Universitesi ( Site 0959)
Izmir, 42000
Turkey
Status: Recruiting Contact: N/A
Facility: Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi ( Site 0961)
Konya, IV2 3UJ
Turkey
Status: Recruiting Contact: N/A
Facility: Raigmore Hospital ( Site 1006)
Inverness, EC1A 7BE
United Kingdom
Status: Recruiting Contact: N/A
Facility: St Bartholomew s Hospital ( Site 1008)
London, SW17 0QT
United Kingdom
Status: Recruiting Contact: N/A
Facility: St Georges University Hospitals NHS Foundation Trust. ( Site 1005)
London,
United Kingdom
Status: Recruiting Contact: N/A